89bio, Inc.
ETNB
$8.10
$0.405.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.60% | 1.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -37.78% | -19.70% | |||
| Operating Income | 37.78% | 19.70% | |||
| Income Before Tax | 39.76% | 20.67% | |||
| Income Tax Expenses | -46.69% | 25.98% | |||
| Earnings from Continuing Operations | 39.78% | 20.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 39.78% | 20.61% | |||
| EBIT | 37.78% | 19.70% | |||
| EBITDA | 37.79% | 19.70% | |||
| EPS Basic | 52.29% | 26.68% | |||
| Normalized Basic EPS | 51.85% | 25.45% | |||
| EPS Diluted | 52.29% | 26.68% | |||
| Normalized Diluted EPS | 51.85% | 25.45% | |||
| Average Basic Shares Outstanding | 26.22% | 8.29% | |||
| Average Diluted Shares Outstanding | 26.22% | 8.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||